Gelonghui, April 5 | According to the latest equity disclosure data of the Stock Exchange, on April 3, 2024, Zhongzhi Pharmaceutical (03737.HK) was granted an increase of 3.36 million shares by Chairman and Executive Director Lai Zhifen on the market at an average price of HK$1.18 per share, involving about HK$3.965 million.
After the increase in holdings, Lai Zhifian's latest shareholding was 543,899,800 shares, and the shareholding ratio increased from 62.59% to 62.98%.
